Shandong Lukang Pharmaceutical Co.,Ltd. (SHA:600789)
China · Delayed Price · Currency is CNY 7.77
+0.05 (0.65%)
Sep 10, 2026, 1:45 PM CST
SHA:600789 Revenue
Shandong Lukang Pharmaceutical had revenue of 1.62B CNY in the quarter ending June 30, 2026, with 9.53% growth. This brings the company's revenue in the last twelve months to 5.85B, down -4.22% year-over-year. In the year 2025, Shandong Lukang Pharmaceutical had annual revenue of 5.77B, down -7.49%.
Revenue (ttm)
5.85B
Revenue Growth
-4.22%
P/S Ratio
1.38
Revenue / Employee
904.30K
Employees
6,469
Market Cap
8.07B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.77B | -466.97M | -7.49% |
| Dec 31, 2024 | 6.23B | 86.37M | 1.41% |
| Dec 31, 2023 | 6.15B | 525.28M | 9.34% |
| Dec 31, 2022 | 5.62B | 697.66M | 14.17% |
| Dec 31, 2021 | 4.92B | 718.67M | 17.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.